Drug OKd in 13 Nations
- Share via
KENILWORTH, N.J. — Drug concern Schering-Plough Corp. said its new antihistamine, which does not act as a sedative, has been approved in 13 countries and is expected to generate worldwide sales between $200 million and $300 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
